Steven P. van Nurden
Chief Executive Officer at Fitzsimons Redevelopment Authority (Colorado)
Profile
Mr. Steven P.
van Nurden is President & Chief Executive Officer at Fitzsimons Redevelopment Authority (Colorado).
He is on the Board of Directors at Anexon, Inc. and Colorado BioScience Association.
Mr. van Nurden also served on the board at Mayo Clinic Ventures.
Steven P. van Nurden active positions
| Companies | Position | Start |
|---|---|---|
Colorado BioScience Association
 Colorado BioScience Association Miscellaneous Commercial ServicesCommercial Services Colorado BioScience Association operates as an association for life sciences. The non-profit company is based in Denver, CO. The company was founded by Steve A. Orndorff. Jennifer Jones Paton has been the CEO of the company since 2016. | Director/Board Member | - |
| Fitzsimons Redevelopment Authority (Colorado) | Chief Executive Officer | - |
Former positions of Steven P. van Nurden
| Companies | Position | End |
|---|---|---|
Anexon, Inc.
 Anexon, Inc. Pharmaceuticals: MajorHealth Technology Anexon, Inc. develops therapeutics for cardiovascular diseases. The firm develops an alternatively spliced variant of brain natriuretic peptide, ANX-042, for the treatment of patients with chronic heart failure and kidney dysfunction. The company was founded in 2006 by Robert D. Simari and is headquartered in Cambridge, MA. | Director/Board Member | - |
Mayo Medical Ventures
 Mayo Medical Ventures Investment ManagersFinance Mayo Medical Ventures (Mayo Medical Ventures) is a venture capital subsidiary of Mayo Clinic founded in 1985. The firm is headquartered in Rochester, Minnesota. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Mayo Medical Ventures
Mayo Medical Ventures Investment ManagersFinance Mayo Medical Ventures (Mayo Medical Ventures) is a venture capital subsidiary of Mayo Clinic founded in 1985. The firm is headquartered in Rochester, Minnesota. | Finance |
Anexon, Inc.
Anexon, Inc. Pharmaceuticals: MajorHealth Technology Anexon, Inc. develops therapeutics for cardiovascular diseases. The firm develops an alternatively spliced variant of brain natriuretic peptide, ANX-042, for the treatment of patients with chronic heart failure and kidney dysfunction. The company was founded in 2006 by Robert D. Simari and is headquartered in Cambridge, MA. | Health Technology |
Colorado BioScience Association
Colorado BioScience Association Miscellaneous Commercial ServicesCommercial Services Colorado BioScience Association operates as an association for life sciences. The non-profit company is based in Denver, CO. The company was founded by Steve A. Orndorff. Jennifer Jones Paton has been the CEO of the company since 2016. | Commercial Services |
| Fitzsimons Redevelopment Authority (Colorado) | Government |
- Stock Market
- Insiders
- Steven P. van Nurden
